Details
Ratings
Pediatr Neurol. 2014 Jun 6
BACKGROUND: In spite of high occurrence of migraine headaches in school-age children, there are currently no approved and widely accepted pharmacologic agents for migraine prophylaxis in children. Our previous open-label study in children revealed the efficacy of cinnarizine, a calcium channel blocker, in migraine prophylaxis. A placebo-controlled trial was conducted to demonstrate the efficacy and safety of cinnarizine in the prophylaxis of migraine in children.
Epilepsia. 2011 Apr;52(4):826-36
Epilepsia. 2011 Apr;52(4):788-93
Intranasal administration of lorazepam is not found to be inferior to intravenous administration for termination of acute convulsive seizures in children